Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s40262-014-0157-y
Published Online: 2014-08-05
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scheen, André J.
Text and Data Mining valid from 2014-08-05
